After more than two years of planning, work has finally started on the site of a planned pharmaceutical manufacturing complex near Dunkirk, New York.

Athenex plans to invest about $1.5 billion in the project.

New York State has earmarked about $200 million to support construction.

Heavy equipment is now busy clearing and leveling the site before the actual construction can start.

Planners say the high tech facility will eventually have about 900 employees making oncology drugs to fight cancer.

And supporters think it will also create spin off jobs and new development.

Dunkirk Town Supervisor Richard Purol said, "Oh it is good. We have lost so many businesses over the years here."

Planners expect the 320,000 square foot facility will be finished sometime in 2020.